Seminars in Cardiothoracic and Vascular Anesthesia

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Corwin, H. L.
Right arrow Articles by Surgenor, S. D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Corwin, H. L.
Right arrow Articles by Surgenor, S. D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Seminars in Cardiothoracic and Vascular Anesthesia, Vol. 6, No. 3, 271-278 (2002)
DOI: 10.1177/108925320200600309

Blood Transfusion Issues in the Critically Ill

Howard L. Corwin, MD

Marcus D. Hampers, MD

Stephen D. Surgenor, MD

Section Critical Care Medicine, Department of Anesthesiology, Dartmouth Hitchcock Medical Center, Dartmouth Medical School, Lebanon, NH 03756

Anemia is a common clinical problem seen in the critically ill and results in a large RBC transfusion requirement for these patients. The view that RBC transfusion is risk-free is no longer tenable today. There is the accumulating evidence that allogeneic blood transfusion is immunosuppressive. More reently, attention has focused on the age of RBCs transfused. Transfused RBCs, especially during the time period immeditely following transfusion, are not normal. The duration of RBC storage may be an important determinant of the efficacy of RBCs as oxygen carriers as well as a determinant of transusion related morbidity. Adding to the controversy about risk/benefit ratio for RBC transfusion are recent data showing that an aggressive RBC transfusion strategy may decrease the likelihood of survival in selected subpopulations of critically ill adults. The optimal hematocrit for the ICU patient remains to be determined. It seems clear that hemoglobin levels falling significantly below the "10/30" threshold can be tolerated. However, it is not clear that this is applicable to the critically ill ICU patient population. Therefore, while hemoglobin levels in the 7-10 mg/dL range are well tolerated in the "stable" "nontressed" patient, this range might not be optimal for the critcally ill patient. Conservative transfusion thresholds as well as strategies to minimize loss of blood and increase the producion of RBCs are important in the management of critically ill patients.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?